Post COVID ConditionNCT06689345
Effect of Non-Invasive Neuromodulation on Primary Chronic Pain, Including Post-COVID-19
A study testing taVNS - transauricular vagal nerve stimulation, rPMS - repetitive peripheric magnetic stimulation and rTMS - repetitive transcranial magnetic stimulation in people with Post COVID Condition and Chronic Pain, run by Federal University of ABC at 1 site in Brazil.
Trial summary
The aim of this study is to analyse whether there is an advantage in adding low-intensity electrical stimulations to the vagus nerve with electrodes in the outer ear to control pain and fatigue in people with primary chronic pain, and in people who have had COVID-19. Read more about this study
- Who is it for?
- Ages 18 to 64 yearsHealthy volunteers can take part
- Conditions the study is for
- Post COVID Condition, Chronic Pain, Healthy
- What is being tested?
- taVNS - transauricular vagal nerve stimulation, rPMS - repetitive peripheric magnetic stimulation and rTMS - repetitive transcranial magnetic stimulation
- Type of treatment
- Injection or infusion, Medical device
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 55 participants
- Where
- 1 siteBrazil
- Study dates
- 21 Apr 2024to 16 Dec 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 64 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Healthy individuals, both sexes, aged between 18 and 40 years (first arm).
- Diagnosis of primary chronic pain (for more than 3 months), such as fibromyalgia (chronic widespread pain), primary chronic headache and orofacial pain, chronic primary visceral pain, post-COVID pain, and chronic primary musculoskeletal pain;
- In the case of post-COVID-19 pain, the symptoms must be present for at least 12 weeks. The complaints of pain, fatigue, and/or changes in mental health should have started after infection by SARS-Cov-2.
Who cannot join
- Individuals who present dysautonomia;
- obese individuals with a high abdominal fat index characterized by a waist/hip ratio of 0.80 for women and 0.95 for men;
- heart disease;
- diabetes mellitus;
- vestibular alterations characterized by the Dix-Hallpike maneuver, supine rotation test, arc test, side-lying maneuver, and post-head-shake nystagmus;
- diagnosis of epilepsy or first-degree family history of epilepsy
Show all 14Show fewer
- fever;
- chronic consumption of alcohol, or other recreational drugs;
- presence of contraindications for the use of non-invasive neuromodulation;
- those who become ill with COVID-19 during the data collection period;
- those who are unable to answer the evaluation questionnaires;
- those with clinical instability;
- those who have a previous history of chronic pain or fatigue before contracting COVID-19;
- those who have neuropathic pain.
Trial locations and contacts
1 site in 1 country.
Brazil1 site
Federal University of ABC
Sâo Bernardo Do Campo, São Paulo, 09606045
About this study
Official title: Effects of Non-invasive Neuromodulation on Post-COVID-19 Syndrome: Multicenter Study
The aim of this study is to analyse whether there is an advantage in adding low-intensity electrical stimulations to the vagus nerve with electrodes in the outer ear to control pain and fatigue in people with primary chronic pain, and in people who have had COVID-19. Several studies have shown that many people with primary chronic pain and also people who have had COVID patients continue to have pain and fatigue that may be due to changes that occur in the brain and the vagus nerve that passes through the neck might cause inflammation. Therefore the aim of this study is to investigate if these electrical stimulations can help improve the condition of the brain and nerve and consequently, the inflammation so that these complaints improve.
This study will be organized as the following: It will begin with an assessment, divided into a part with questionnaires and another with specific tests. The questionnaires are aimed at understanding volunteer's characteristics, pain, fatigue, inflammation, sleep, quality of life, and the presence of symptoms of anxiety and depression. Next, the volunteer will undergo two tests to assess the behavior of his/her brain. They are performed using EEG electroencephalography and transcranial magnetic stimulation (TMS).
Read more
- Quantitative EEG at rest - In this technique, a cap with electrodes is placed on volunteer's head, in contact with hair, which are connected through a gel. The volunteer needs to remain still for 6 minutes with eyes closed, sitting in a comfortable chair.
- TMS with EEG - First, the volunteer will be asked to honestly answer the questions in the safety questionnaire for using this technique. Honest answers will eliminate the risks associated with this evaluation. Next, the volunteer's skin will be cleaned with alcohol and a special paste and place three self-adhesive electrodes on the muscle of the volunteer's hand, in a muscle called the interosseous, on the side where he/she writes. These electrodes will only capture the electrical activity of the muscle. Next, a series of magnetic pulses will be administered to the volunteer's skull, in the area that controls the hand muscle. It will contract with each pulse and, with this, so that the functioning of this connection can be understood. At the same time, the EEG device will capture the brain activities that occur during this TMS stimulation. During this exam, the volunteer may feel anything from no stimulation to muscle contractions that move his/her hand. Some people also experience redness under the electrodes, fatigue, or muscle/joint pain.
After the assessments, volunteers will be randomly selected to receive neuromodulation sessions using low-intensity electrical stimulation of the vagus nerve, using electrodes in the outer ear (active group), or sessions that only simulate this neuromodulation (sham, or placebo, group). This will occur for five consecutive days, starting on the day of the assessment. This stimulation is very weak and may not even be felt by the person receiving it. This technique is safe and the most that may occur is redness or itching of the skin. A few people may also experience tingling, a burning sensation or momentary local pain, fatigue, drowsiness, difficulty concentrating and a feeling of nervousness during or after the stimulation.
At the end of the 5 days of electrical stimulation, the same initial assessments will be repeated to see if anything has changed in the volunteer's brain, heart rate, blood pressure, pain, fatigue, inflammation, sleep, quality of life, depression, and anxiety.
- Conditions
- Post COVID Condition, Chronic Pain, Healthy
- Being tested
- taVNS - transauricular vagal nerve stimulation, rPMS - repetitive peripheric magnetic stimulation, rTMS - repetitive transcranial magnetic stimulation, taVNS sham
- Keywords
- neuromodulation, chronic pain, covid-19, TMS-EEG, vagal nerve
- Medical subject headings
- Post-Acute COVID-19 Syndrome, Chronic Pain, COVID-19
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
taVNS - transauricular vagal nerve stimulationDevice
30 minutes of electrical stimulation on the afferent portion of the vagal nerve on the cymba conchae of the ear, in the following configuration: 30 seg ramp up, 30 seg on, 30 seg off in intensity on which the volunteer feels a light tingling.
rPMS - repetitive peripheric magnetic stimulationDevice
Magnetic stimulation on the efferent portion of the vagal nerve on the neck, on the following configuration: 20Hz, 25 pulses in the trein, in every inhalation, for 20 inhalations with 50% of machine capacity (500 pulses total).
rTMS - repetitive transcranial magnetic stimulationDevice
rTMS intermitent theta- burst on the left DLPFC, on the following configuration: 50 Hz in treins of 5Hz, with 110% of the resting motor limiar and 600 pulses in 3 minutes.
taVNS shamDevice
Simulated taVNS (SHAM) on helix left ear, that is the same as taVNS, but during only 1 minute
| Study group | Role | What they receive |
|---|---|---|
| Healthy subjects | Other | Once a week, each subject will receive a random stimulation in one of the following areas: (i) the afferent portion of the vagal nerve on the Cymba Conchae of the left ear (taVNS); (ii) rPMS on an efferent portion of the vagal nerve on the neck; (iii) rTMS intermittent theta- burst on the left DLPFC; (iv) simulated taVNS (SHAM) on helix left ear or. Receives: Device: taVNS - transauricular vagal nerve stimulation; Device: rPMS - repetitive peripheric magnetic stimulation; Device: rTMS - repetitive transcranial magnetic stimulation; Device: taVNS sham |
| Chronic Pain and post Covid Syndrom - Active | Experimental | These volunteers will receive 30 minutes of taVNS on the afferent portion of the vagal nerve on the ears. Receives: Device: taVNS - transauricular vagal nerve stimulation |
| Chronic Pain and post Covid Syndrom - Sham | Sham comparator | These volunteers will receive 30 minutes of simulated taVNS on the afferent portion of the vagal nerve on the ears. For this, the equipment will be programmed to be on only for 1 minute. Receives: Device: taVNS sham |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pain
It will be assessed through the Brief Pain Inventory (BPI), that assess place and pain intensity and its impact in life and by multidimensional pain assessment instruments to evaluate pain experience and self-efficacy
Measured: 5 days
Secondary outcomes (4)
Heart rate variability and blood preasure
It will be done using a chest polar and a sphygmomanometer.
Measured: 5 days
Pressure pain threshold.
Assessed through handgrip dynamometry.
Measured: 5 days
TMS-Evoked potential
TMS-Evoked Potential is a measure derived from TMS stimulus on the brain which represent a brain reactivity to exogenous stimulus
Measured: 5 days
Disautonomy, fatigue and mental health
Dysautonomia will be assessed through TMS-EEG. Fatigue will be assessed by physical, cognitive and psychosocial fatigue scales and fatigue perception questionnaire. Mental health will be assessed by anxiety, depression and sleep quality questionnaires. Quality of life will be assessed by a specific questionnaire.
Measured: 5 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Nov 2024
- Study start21 Apr 2024
- Primary completion16 Dec 2024 (estimated)
- Study completion16 Dec 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Post COVID ConditionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Sequential
- Model description
- First, we will test the savety and effects of neuromodulation using four different tecniques on autonomous system of healthy people. Then, we will test the effect of neuromodulation through, vagal stimulation, on pain, fatigue, mental healthy and disautonomy of people with primary chronic pain and/or post-COVID syndrom. For this, active and sham stimulations will be compared.
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 55 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Federal University of ABC
- Sponsor type
- University, hospital or other
- Collaborators
- University of Sao Paulo, Coordination for the Improvement of Higher Education Personnel
- Responsible party
- Sponsor
- Investigators
- Tiago S Lopes, PhD, Study chair, Federal University of ABC
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06689345
- Sponsor's protocol ID
- U1111-1293-2751
- Status last verified
- Sep 2024
- First submitted
- 27 Sep 2024
- Last updated
- 14 Nov 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Nov 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Non-invasive Neuromodulation on Post-COVID-19 Syndrome: Multicenter Study
- ClinicalTrials.gov ID
- NCT06689345
- Acronym / sponsor ID
- U1111-1293-2751
- Conditions
- Post COVID Condition, Chronic Pain, Healthy
- Keywords
- neuromodulation, chronic pain, covid-19, TMS-EEG, vagal nerve
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 55 participants (estimated)
- Lead sponsor
- Federal University of ABCUniversity, hospital or other
- Collaborators
- University of Sao Paulo, Coordination for the Improvement of Higher Education Personnel
- Study start
- 21 Apr 2024 (actual)
- Primary completion
- 16 Dec 2024 (estimated)
- Study completion
- 16 Dec 2024 (estimated)
- First posted
- 14 Nov 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to analyse whether there is an advantage in adding low-intensity electrical stimulations to the vagus nerve with electrodes in the outer ear to control pain and fatigue in people with primary chronic pain, and in people who have had COVID-19. Several studies have shown that many people with primary chronic pain and also people who have had COVID patients continue to have pain and fatigue that may be due to changes that occur in the brain and the vagus nerve that passes through the neck might cause inflammation. Therefore the aim of this study is to investigate if these electrical stimulations can help improve the condition of the brain and nerve and consequently, the inflammation so that these complaints improve.
This study will be organized as the following: It will begin with an assessment, divided into a part with questionnaires and another with specific tests. The questionnaires are aimed at understanding volunteer's characteristics, pain, fatigue, inflammation, sleep, quality of life, and the presence of symptoms of anxiety and depression. Next, the volunteer will undergo two tests to assess the behavior of his/her brain. They are performed using EEG electroencephalography and transcranial magnetic stimulation (TMS).
- Quantitative EEG at rest - In this technique, a cap with electrodes is placed on volunteer's head, in contact with hair, which are connected through a gel. The volunteer needs to remain still for 6 minutes with eyes closed, sitting in a comfortable chair.
- TMS with EEG - First, the volunteer will be asked to honestly answer the questions in the safety questionnaire for using this technique. Honest answers will eliminate the risks associated with this evaluation. Next, the volunteer's skin will be cleaned with alcohol and a special paste and place three self-adhesive electrodes on the muscle of the volunteer's hand, in a muscle called the interosseous, on the side where he/she writes. These electrodes will only capture the electrical activity of the muscle. Next, a series of magnetic pulses will be administered to the volunteer's skull, in the area that controls the hand muscle. It will contract with each pulse and, with this, so that the functioning of this connection can be understood. At the same time, the EEG device will capture the brain activities that occur during this TMS stimulation. During this exam, the volunteer may feel anything from no stimulation to muscle contractions that move his/her hand. Some people also experience redness under the electrodes, fatigue, or muscle/joint pain.
After the assessments, volunteers will be randomly selected to receive neuromodulation sessions using low-intensity electrical stimulation of the vagus nerve, using electrodes in the outer ear (active group), or sessions that only simulate this neuromodulation (sham, or placebo, group). This will occur for five consecutive days, starting on the day of the assessment. This stimulation is very weak and may not even be felt by the person receiving it. This technique is safe and the most that may occur is redness or itching of the skin. A few people may also experience tingling, a burning sensation or momentary local pain, fatigue, drowsiness, difficulty concentrating and a feeling of nervousness during or after the stimulation.
At the end of the 5 days of electrical stimulation, the same initial assessments will be repeated to see if anything has changed in the volunteer's brain, heart rate, blood pressure, pain, fatigue, inflammation, sleep, quality of life, depression, and anxiety.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Sequential
- Masking
- Double blind (participant, investigator)
- Number of arms
- 3
- Model description
- First, we will test the savety and effects of neuromodulation using four different tecniques on autonomous system of healthy people. Then, we will test the effect of neuromodulation through, vagal stimulation, on pain, fatigue, mental healthy and disautonomy of people with primary chronic pain and/or post-COVID syndrom. For this, active and sham stimulations will be compared.
| Arm | Type | Receives |
|---|---|---|
| Healthy subjects | Other | Device: taVNS - transauricular vagal nerve stimulation, Device: rPMS - repetitive peripheric magnetic stimulation, Device: rTMS - repetitive transcranial magnetic stimulation, Device: taVNS shamOnce a week, each subject will receive a random stimulation in one of the following areas: (i) the afferent portion of the vagal nerve on the Cymba Conchae of the left ear (taVNS); (ii) rPMS on an efferent portion of the vagal nerve on the neck; (iii) rTMS intermittent theta- burst on the left DLPFC; (iv) simulated taVNS (SHAM) on helix left ear or. |
| Chronic Pain and post Covid Syndrom - Active | Experimental | Device: taVNS - transauricular vagal nerve stimulationThese volunteers will receive 30 minutes of taVNS on the afferent portion of the vagal nerve on the ears. |
| Chronic Pain and post Covid Syndrom - Sham | Sham comparator | Device: taVNS shamThese volunteers will receive 30 minutes of simulated taVNS on the afferent portion of the vagal nerve on the ears. For this, the equipment will be programmed to be on only for 1 minute. |
Who may qualify
- Ages
- 18 to 64 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Healthy individuals, both sexes, aged between 18 and 40 years (first arm).
- Diagnosis of primary chronic pain (for more than 3 months), such as fibromyalgia (chronic widespread pain), primary chronic headache and orofacial pain, chronic primary visceral pain, post-COVID pain, and chronic primary musculoskeletal pain;
- In the case of post-COVID-19 pain, the symptoms must be present for at least 12 weeks. The complaints of pain, fatigue, and/or changes in mental health should have started after infection by SARS-Cov-2.
Key exclusion criteria (14 listed)
- Individuals who present dysautonomia;
- obese individuals with a high abdominal fat index characterized by a waist/hip ratio of 0.80 for women and 0.95 for men;
- heart disease;
- diabetes mellitus;
- vestibular alterations characterized by the Dix-Hallpike maneuver, supine rotation test, arc test, side-lying maneuver, and post-head-shake nystagmus;
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| taVNS - transauricular vagal nerve stimulation30 minutes of electrical stimulation on the afferent portion of the vagal nerve on the cymba conchae of the ear, in the following configuration: 30 seg ramp up, 30 seg on, 30 seg off in intensity on which the volunteer feels a light tingling. | Device | Chronic Pain and post Covid Syndrom - Active, Healthy subjects |
| rPMS - repetitive peripheric magnetic stimulationMagnetic stimulation on the efferent portion of the vagal nerve on the neck, on the following configuration: 20Hz, 25 pulses in the trein, in every inhalation, for 20 inhalations with 50% of machine capacity (500 pulses total). | Device | Healthy subjects |
| rTMS - repetitive transcranial magnetic stimulationrTMS intermitent theta- burst on the left DLPFC, on the following configuration: 50 Hz in treins of 5Hz, with 110% of the resting motor limiar and 600 pulses in 3 minutes. | Device | Healthy subjects |
| taVNS shamSimulated taVNS (SHAM) on helix left ear, that is the same as taVNS, but during only 1 minute | Device | Chronic Pain and post Covid Syndrom - Sham, Healthy subjects |
Primary outcome
Pain
Time frame: 5 days
It will be assessed through the Brief Pain Inventory (BPI), that assess place and pain intensity and its impact in life and by multidimensional pain assessment instruments to evaluate pain experience and self-efficacy
4 secondary outcomes
Heart rate variability and blood preasure
Time frame: 5 days
Pressure pain threshold.
Time frame: 5 days
TMS-Evoked potential
Time frame: 5 days
Disautonomy, fatigue and mental health
Time frame: 5 days
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Nov 2024.
- Individual participant dataSharing planned: No
Related trials for Post COVID Condition
Not yet recruitingPhase 1
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Post-Acute COVID-19 Syndrome
Recruiting
Home-Based Exercise Tele-Rehabilitation After COVID-19
Post SARS-CoV2 (COVID-19)
Recruiting
Whole-body Cryotherapy in Those With Chronic Fatigue: A Feasibility Study
ME/CFS, Fibromyalgia (FM)
Not yet recruitingPhase 3
The Study of Brave-LC LDN Treatment Trial
Post-acute COVID-19 Syndrome
Active, not recruitingObservational study
Epigenetic Changes in Long COVID Patients
Long COVID-19 Syndrome, Long COVID Symptoms
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Tiago S Lopes, PhD study chair
Federal University of ABC
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing taVNS - transauricular vagal nerve stimulation, rPMS - repetitive peripheric magnetic stimulation and rTMS - repetitive transcranial magnetic stimulation in people with Post COVID Condition and Chronic Pain, run by Federal University of ABC at 1 site in Brazil.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 14 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pain (time frame: 5 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Nov 2024.